The current NAV of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) is ₹25.19, as of 16th April 2026.

The ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) was launched on 13th July 2018. This mutual fund's past returns are as follows:

• 1 Year Returns: -0.87%
• 3 Year Returns: 17.47%
• 5 Year Returns: 7.43%

The top sectors ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) has invested in are as follows:

• Pharmaceuticals | 82.80%
• Others | 4.80%
• Labs & Life Sciences Services | 3.44%
• Retail - Speciality | 2.73%
• Miscellaneous | 2.68%

This data is as on 16th April 2026.

The top 5 holdings for ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) are as follows:

• Sun Pharmaceutical Industries Ltd | 12.11%
• Cipla Ltd | 9.23%
• Mankind Pharma Ltd | 7.01%
• Biocon Ltd | 6.08%
• Dr Reddy's Laboratories Ltd | 5.97%

This data is as on 16th April 2026.

The asset allocation for ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) is as follows:

• Equity | 97.62%
• Cash & Equivalents | 2.35%
• Treasury Bills | 0.03%

This data is as on 16th April 2026.

The AUM (i.e. assets under management) of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) is ₹6293.14 Cr as of 16th April 2026.

The expense ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) Plan is 1.05 as of 16th April 2026.

The volatility or standard deviation for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) is 13.47

Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

The Sharpe ratio for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) is 0.25

The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

The Sortino Ratio for the ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) is 0.03

The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.

The PE ratio of ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW) is 32.31, while category PE ratio is 41.25.